Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zamir Halpern

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|January 17, 2012
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-upShira Zelber-Sagi, Roni Lotan, Amir Shlomai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2006
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver diseaseShira Zelber-Sagi, Ada Kessler, Eli Brazowsky, et al.
Familial Cancer|March 31, 2015
Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African JewsGuy Rosner, Dani Bercovich, Yael Etzion Daniel, et al.
Gastrointestinal Endoscopy|August 23, 2005
Initial experience of videocapsule endoscopy for diagnosing small-bowel tumors in patients with GI polyposis syndromesOlga Barkay, Menachem Moshkowitz, Zvi Fireman, et al.
World Journal of Gastroenterology|January 18, 2013
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantificationShira Zelber-Sagi, Muriel Webb, Nimer Assy, et al.
Inflammatory Bowel Diseases|September 24, 2009
CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune systemIris Dotan, Lael Werner, Sharon Vigodman, et al.
Journal of Hepatology|June 27, 2012
The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistanceAmir Shlomai, Maya Mouler Rechtman, Ela Olga Burdelova, et al.
Frontiers in Immunology|November 30, 2018
Impaired COMMD10-Mediated Regulation of Ly6C<sup>hi</sup> Monocyte-Driven Inflammation Disrupts Gut Barrier FunctionOdelia Mouhadeb, Shani Ben Shlomo, Keren Cohen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammationChen Varol, Isabel Zvibel, Lior Spektor, et al.
Inflammatory Bowel Diseases|April 20, 2013
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel diseaseNitsan Maharshak, Shani Shenhar-Tsarfaty, Nimrod Aroyo, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|January 17, 2012
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-upShira Zelber-Sagi, Roni Lotan, Amir Shlomai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2006
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver diseaseShira Zelber-Sagi, Ada Kessler, Eli Brazowsky, et al.
Familial Cancer|March 31, 2015
Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African JewsGuy Rosner, Dani Bercovich, Yael Etzion Daniel, et al.
Gastrointestinal Endoscopy|August 23, 2005
Initial experience of videocapsule endoscopy for diagnosing small-bowel tumors in patients with GI polyposis syndromesOlga Barkay, Menachem Moshkowitz, Zvi Fireman, et al.
World Journal of Gastroenterology|January 18, 2013
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantificationShira Zelber-Sagi, Muriel Webb, Nimer Assy, et al.
Inflammatory Bowel Diseases|September 24, 2009
CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune systemIris Dotan, Lael Werner, Sharon Vigodman, et al.
Journal of Hepatology|June 27, 2012
The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistanceAmir Shlomai, Maya Mouler Rechtman, Ela Olga Burdelova, et al.
Frontiers in Immunology|November 30, 2018
Impaired COMMD10-Mediated Regulation of Ly6C<sup>hi</sup> Monocyte-Driven Inflammation Disrupts Gut Barrier FunctionOdelia Mouhadeb, Shani Ben Shlomo, Keren Cohen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammationChen Varol, Isabel Zvibel, Lior Spektor, et al.
Inflammatory Bowel Diseases|April 20, 2013
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel diseaseNitsan Maharshak, Shani Shenhar-Tsarfaty, Nimrod Aroyo, et al.
Pageof 12